QUINOLINE OR QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF FIBROBLAST GROWTH FACTOR RECEPTORS

Details for Australian Patent Application No. 2002343997 (hide)

Owner KIRIN BEER KABUSHIKI KAISHA

Inventors MIWA, Atsushi; YOSHINO, Tetsuya; OSAWA, Tatsushi; SAKAI, Teruyuki; SHIMIZU, Toshiyuki; FUJIWARA, Yasunari

Pub. Number AU-A-2002343997

PCT Number PCT/JP02/10803

PCT Pub. Number WO2003/033472

Priority 2001-319826 17.10.01 JP; 2002-167652 07.06.02 JP

Filing date 17 October 2002

Wipo publication date 28 April 2003

International Classifications

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 239/88 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 031/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 031/47 - Quinolines

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 031/5377

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/18 Drugs for disorders of the alimentary tract or the digestive system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 013/12 Drugs for disorders of the urinary system

A61P 015/00 Drugs for genital or sexual disorders

A61P 035/00 Antineoplastic agents

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 2001-319826 17.10.01 JP; 2002-167652 07.06.02 JP

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002343997

1 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002343998-Alkaline dry cell

2002343996-SUBSTRATE WITH TRANSPARENT CONDUCTIVE OXIDE FILM AND PRODUCTION METHOD THEREFOR, AND PHOTOELECTRIC CONVERSION ELEMENT